Metabolic and cardiovascular effects of adrenaline and alprenolol (Aptin®) in human subjects
- 1 November 1969
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 2 (1) , 40-45
- https://doi.org/10.1007/bf00404185
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Substrat- und Metabolitverschiebungen im Blut nach Adrenalin und β-ReceptorenblockernKlinische Wochenschrift, 1967
- Pharmacological Properties of H 56/28—a ß‐Adrenergic Receptor AntagonistActa Pharmacologica et Toxicologica, 1967
- Hemodynamic Effects of Propranolol1and H 56/282in Man—a Comparative Study of two β‐adrenergic Receptor AntagonistsActa Pharmacologica et Toxicologica, 1967
- The Effect of a ß‐Adrenergic Receptor Antagonist (H 56/28) on Lipid MobilizationActa Pharmacologica et Toxicologica, 1967
- The influence of an adrenergic β-receptor blocking agent (DL-4-(2-isopropylamino-1-hydroxylethyl) methanesulphonanilide, MJ 1999) on some of the metabolic effects of adrenaline in manLife Sciences, 1967
- Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytomaThe American Journal of Cardiology, 1966
- Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in manThe American Journal of Cardiology, 1966
- The effect of epinephrine on immunoreactive insulin levels in man.Journal of Clinical Investigation, 1966
- Some factors influencing the release of noradrenaline into the blood following sympathetic stimulationLife Sciences, 1964
- EFFECT OF ADRENERGIC BLOCKADE ON GLUCOSE AND FATTY-ACID MOBILISATION IN MANThe Lancet, 1962